7,457
Views
41
CrossRef citations to date
0
Altmetric
Review

Multidimensional social and cultural norms influencing HPV vaccine hesitancy in Asia

ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon, , & ORCID Icon show all
Pages 1611-1622 | Received 30 Jan 2020, Accepted 11 Apr 2020, Published online: 19 May 2020

References

  • WHO. Cancer; 2019a [accessed 2020 Jan 15]. https://www.who.int/cancer/prevention/diagnosis-screening/cervical-cancer/en/
  • Vu M, Yu J, Awolude OA, Chuang L. Cervical cancer worldwide. Curr Probl Cancer. 2018 Sep 1;42(5):457–65. doi:10.1016/j.currproblcancer.2018.06.003.
  • Garland SM, Bhatla N, Ngan HY. Cervical cancer burden and prevention strategies: Asia oceania perspective. Cancer Epidemiol Biomarkers Prev. 2012 Sep 1;21(9):1414–22. doi:10.1158/1055-9965.EPI-12-0164.
  • Cervical Cancer Action. Global maps: global progress in HPV vaccination: status: June 2017; 2017 [accessed 2020 Jan 15]. http://www.cervicalcanceraction.org/comments/comments3.php.
  • Lu CY, Santosham M. Survey of national immunization programs and vaccine coverage rates in Asia Pacific countries. Vaccine. 2012 Mar 16;30(13):2250–55. doi:10.1016/j.vaccine.2011.10.070.
  • Choi HC, Leung GM, Woo PP, Jit M, Wu JT. Acceptability and uptake of female adolescent HPV vaccination in Hong Kong: a survey of mothers and adolescents. Vaccine. 2013 Dec 17;32(1):78–84. doi:10.1016/j.vaccine.2013.10.068.
  • Yuen WW, Lee A, Chan PK, Tran L, Sayko E. Uptake of human papillomavirus (HPV) vaccination in Hong Kong: facilitators and barriers among adolescent girls and their parents. PLoS One. 2018 Mar 15;13(3):e0194159. doi:10.1371/journal.pone.0194159.
  • Chen JM, Leung DY. Factors associated with human papillomavirus vaccination among Chinese female university students in Hong Kong. Am Int J Soc Sci. 2016;3:56–62.
  • Lee SG, Jeon SY, Park O, Kim MY, Yang HI, Park EY. Vaccination coverage of adults aged above 19 years using mixed-mode random digit dialing (RDD) survey. J Korean Soc Matern Child Health. 2015;19:58–70. doi:10.21896/jksmch.2015.19.1.58.
  • Oh JK, Jeong BY, Yun EH, Lim MK. Awareness of and attitudes toward human papillomavirus vaccination among adults in Korea: 9-year changes in nationwide surveys. Cancer Res Treat. 2018 Apr;50(2):436. doi:10.4143/crt.2017.174.
  • Chirayil EI, Thompson CL, Burney S. Predicting human papilloma virus vaccination and pap smear screening intentions among young Singaporean women using the theory of planned behavior. Sage Open. 2014;4:1–10. doi:10.1177/2158244014554961.
  • Muhamad NA, Buang SN, Jaafar S, Jais R, Tan PS, Mustapha N, Aris T, Sulaiman LH, Murad S. Achieving high uptake of human papillomavirus vaccination in Malaysia through school-based vaccination programme. BMC Public Health. 2018 Dec;18(1):1402. doi:10.1186/s12889-018-6316-6.
  • Klinsupa W, Pensuk P, Thongluan J, Boonsut S, Tragoolpua R, Yoocharoen P, Jiamsiri S. O16. 3 Hpv vaccine introduction in thailand. Sex Transm Infect. 2015;91(Suppl 2):A61. doi:10.1136/sextrans-2015-052270.167.
  • Ueda Y, Enomoto T, Sekine M, Egawa-Takata T, Morimoto A, Kimura T. Japan’s failure to vaccinate girls against human papillomavirus. Am J Obstet Gynecol. 2015 Mar 1;212(3):405–06. doi:10.1016/j.ajog.2014.11.037.
  • Hanley SJ, Yoshioka E, Ito Y, Kishi R. HPV vaccination crisis in Japan. Lancet. 2015;385(9987):2571. doi:10.1016/S0140-6736(15)61152-7.
  • WHO. Ten threats to global health in 2019; 2019 [accessed 2020 Jan 15]. https://www.who.int/news-room/feature-stories/ten-threats-to-global-health-in-2019.
  • Karafillakis E, Simas C, Jarrett C, Verger P, Peretti-Watel P, Dib F, De Angelis S, Takacs J, Ali KA, Pastore Celentano L, et al. HPV vaccination in a context of public mistrust and uncertainty: a systematic literature review of determinants of HPV vaccine hesitancy in Europe. Hum Vaccin Immunother. 2019 Feb;11:1–3. doi:10.1080/21645515.2018.1564436.
  • Larson HJ, Wilson R, Hanley S, Parys A, Paterson P. Tracking the global spread of vaccine sentiments: the global response to Japan’s suspension of its HPV vaccine recommendation. Hum Vaccin Immunother. 2014;10(9):2543–50. doi:10.4161/21645515.2014.969618.
  • Young A. HPV vaccine acceptance among women in the Asian Pacific: a systematic review of the literature. Asian Pac J Cancer Prev. 2010;11(3):641–49. https://pubmed.ncbi.nlm.nih.gov/21039030/PMID:21039030.
  • Santhanes D, Yong CP, Yap YY, San Saw P, Chaiyakunapruk N, Khan TM. Factors influencing intention to obtain the HPV vaccine in South East Asian and Western Pacific regions: a systematic review and meta-analysis. Sci Rep. 2018 Feb 26;8(1):1–1. doi:10.1038/s41598-018-21912-x.
  • Toh ZQ, Licciardi PV, Russell FM, Garland SM, Batmunkh T, Mulholland EK. Cervical cancer prevention through HPV vaccination in low-and middle-income countries in Asia. Asian Pac J Cancer Prev. 2017;18(9):2339. doi:10.22034/APJCP.2017.18.9.2339.
  • Saint Arnault D, Woo S. Testing the influence of cultural determinants on help-seeking theory. Am J Orthopsychiatry. 2018;88(6):650–60. doi:10.1037/ort0000353.
  • Wong LP, Wong PF, AbuBakar S. Vaccine hesitancy and the resurgence of vaccine preventable diseases: the way forward for Malaysia, a Southeast Asian country. Hum Vaccin Immunother. 2020. in press. doi:10.1080/21645515.2019.1706935.
  • McCaffery K, Forrest S, Waller J, Desai M, Szarewski A, Wardle J. Attitudes towards HPV testing: a qualitative study of beliefs among Indian, Pakistani, African-Caribbean and white British women in the UK. Br J Cancer. 2003 Jan;88(1):42. doi:10.1038/sj.bjc.6600686.
  • McCaffery K, Waller J, Nazroo J, Wardle J. Social and psychological impact of HPV testing in cervical screening: a qualitative study. Sex Transm Infect. 2006 Apr 1; 82(2):169–74. doi:10.1136/sti.2005.016436.
  • Daley EM, Vamos CA, Wheldon CW, Kolar SK, Baker EA. Negative emotions and stigma associated with a human papillomavirus test result: a comparison between human papillomavirus–positive men and women. J Health Psychol. 2015;20(8):1073–82. doi:10.1177/1359105313507963.
  • Wong LP. An exploration of knowledge, attitudes and behaviors’ of young multiethnic Muslim-majority society in Malaysia in relation to reproductive and premarital sexual practices. BMC Public Health. 2012;12:865. doi:10.1186/1471-2458-12-865.
  • Meites E, Szilagyi PG, Chesson HW, Unger ER, Romero JR, Markowitz LE. Human papillomavirus vaccination for adults: updated recommendations of the Advisory Committee on Immunization Practices. Am J Transplant. 2019 Nov 1;19(11):3202–06. doi:10.1111/ajt.15633.
  • Valdez A, Stewart SL, Tanjasari SP, Levy V, Garza A. Design and efficacy of a multilingual, multicultural HPV vaccine education intervention. J Commun Healthc. 2015 Jul 1;8(2):106–18. doi:10.1179/1753807615Y.0000000015.
  • Loke AY, Chan AC, Wong YT. Facilitators and barriers to the acceptance of human papillomavirus (HPV) vaccination among adolescent girls: a comparison between mothers and their adolescent daughters in Hong Kong. BMC Res Notes. 2017 Dec;10(1):390. doi:10.1186/s13104-017-2734-2.
  • Shaikh MY, Hussaini MF, Narmeen M, Effendi R, Paryani NS, Ahmed A, Khan M, Obaid H. Knowledge, Attitude, and Barriers Towards Human Papillomavirus (HPV) Vaccination Among Youths of Karachi, Pakistan. Cureus. 2019 Nov 12;11(11):e6134. doi:10.7759/cureus.6134.
  • Jaspers L, Budiningsih S, Wolterbeek R, Henderson FC, Peters AA. Parental acceptance of human papillomavirus (HPV) vaccination in Indonesia: a cross-sectional study. Vaccine. 2011;29:7785–93. doi:10.1016/j.vaccine.2011.07.107.
  • Grandahl M, Paek SC, Grisurapong S, Sherer P, Tyden T, Lundberg P. Parents’ knowledge, beliefs, and acceptance of the HPV vaccination in relation to their socio-demographics and religious beliefs: a cross-sectional study in Thailand. PLoS One. 2018 Feb 15;13(2):e0193054. doi:10.1371/journal.pone.0193054.
  • Sopian MM, Shaaban J, Yusoff SS, Mohamad WM. Knowledge, Decision-Making and Acceptance of Human Papilloma Virus Vaccination among Parents of Primary School Students in Kota Bharu, Kelantan, Malaysia. Asian Pac J Cancer Prev. 2018;19(6):1509. doi:10.22034/APJCP.2018.19.6.1509.
  • Reno JE, O’Leary S, Garrett K, Pyrzanowski J, Lockhart S, Campagna E, Barnard J, Dempsey AF. Improving provider communication about HPV vaccines for vaccine-hesitant parents through the use of motivational interviewing. J Health Commun. 2018 Apr 3;23(4):313–20. doi:10.1080/10810730.2018.1442530.
  • Kasting ML, Shapiro GK, Rosberger Z, Kahn JA, Zimet GD. Tempest in a teapot: a systematic review of HPV vaccination and risk compensation research. Hum Vaccin Immunother. 2016;12(6):1435–50. doi:10.1080/21645515.2016.1141158.
  • Marlow LA, Wardle J, Forster AS, Waller J. Ethnic differences in human papillomavirus awareness and vaccine acceptability. J Epidemiol Community Health. 2009 Dec 1;63(12):1010–15. doi:10.1136/jech.2008.085886.
  • Low WY. Malaysian youth sexuality: issues and challenges. J Health Transl Med. 2009 Jun 29;12(1):3–14. doi:10.22452/jummec.vol12no1.2.
  • Berliana SM, Utami ED, Efendi F, Kurniati A. Premarital sex initiation and the time interval to first marriage among Indonesians. Bull Indones Econ Stud. 2018 May 4;54(2):215–32. doi:10.1080/00074918.2018.1440067.
  • Chan CS. Asian-American adolescents: issues in the expression of sexuality. Sexual cultures and the construction of adolescent identities. Philadelphia (PA): Temple University Press; 1994. p. 88–99.
  • Wong LP. Young multiethnic women’s attitudes toward the HPV vaccine and HPV vaccination. Int J Gynecol Obstet. 2008 Nov;103(2):131–35. doi:10.1016/j.ijgo.2008.07.005.
  • Hussain S, Bharadwaj M, Nasare V, Kumari M, Sharma S, Hedau S, Das BC. Human papillomavirus infection among young adolescents in India: impact of vaccination. J Med Virol. 2012;84(2):298–305. doi:10.1002/jmv.22261.
  • Best AL, Thompson EL, Adamu AM, Logan R, Delva J, Thomas M, Cunningham E, Vamos C, Daley E. Examining the Influence of Religious and Spiritual Beliefs on HPV Vaccine Uptake Among College Women. J Relig Health. 2019 Dec 1;58(6):2196–207. doi:10.1007/s10943-019-00890-y.
  • Carnegie E, Whittaker A, Gray Brunton C, Hogg R, Kennedy C, Hilton S, Harding S, Pollock KG, Pow J. Development of a cross-cultural HPV community engagement model within Scotland. Health Educ J. 2017 Jun;76(4):398–410. doi:10.1177/0017896916685592.
  • Skinner SR, Szarewski A, Romanowski B, Garland S, Lazcano E, Salmerón J. Efficacy, safety and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine in women over 25 years: 4-year interim follow-up of the double-blind, randomised VIVIANE study. Lancet. 2014 Dec 20;384:2213–27. doi:10.1016/S0140-6736(14)60920-X.
  • McSeveney M. FDA approves expanded use of Gardasil 9 to include individuals 27 through 45 years old; 2018 Oct 05 [accessed 2020 Jan 1]. https://www.fda.gov/news-events/press-announcements/fda-approves-expanded-use-gardasil-9-include-individuals-27-through-45-years-old.
  • Lin Y, Lin Z, He F, Chen H, Lin X, Zimet GD, Alias H, He S, Hu Z, Wong LP. HPV vaccination intent and willingness to pay for 2-, 4-, and 9-valent HPV vaccines: a study of adult women aged 27–45 years in China. Vaccine. 2020 Feb 29;38(14):3021–30. doi:10.1016/j.vaccine.2020.02.042.
  • Rumun AJ. Influence of religious beliefs on healthcare practice. Inter J Edu Res. 2014;2:37–48.
  • Makleff S, Wilkins R, Wachsmann H, Gupta D, Wachira M, Bunde W, Radhakrishnan U, Cislaghi B, Baum SE. Exploring stigma and social norms in women’s abortion experiences and their expectations of care. Sex Reprod Health Matters. 2019 Nov 29;27(3):1661753. doi:10.1080/26410397.2019.1661753.
  • Ayele TT. A review on traditionally used medicinal plants/herbs for cancer therapy in Ethiopia: current status, challenge and future perspectives. Organic Chem Curr Res. 2018;7(192):2161–401. doi:10.4172/2161-0401.1000192.
  • Kuruppu AI, Paranagama P, Goonasekara C. Medicinal plants commonly used against cancer in traditional medicine formulae in Sri Lanka. Saudi Pharm J. 2019 Feb 7;27(4):565–73. doi:10.1016/j.jsps.2019.02.004.
  • Ma Y, Chen M, Guo Y, Liu J, Chen W, Guan M, Wang Y, Zhao X, Wang X, Li H, et al. Prevention and treatment of infectious diseases by traditional Chinese medicine: a commentary. Apmis. 2019 May;127(5):372–84. doi:10.1111/apm.12928.
  • Hill J, Seguin R, Phanga T, Manda A, Chikasema M, Gopal S, Smith JS. Facilitators and barriers to traditional medicine use among cancer patients in Malawi. PLoS One. 2019;14(10):e0223853. doi:10.1371/journal.pone.0223853.
  • Skrbo A, Masic I. The Role and Characteristics of Collections of Folk Recepies in the Folk and Traditional Medicine of Bosnia and Herzegovina. Mater Sociomed. 2017 Sep;29(3):219. doi:10.5455/msm.2017.29.219-227.
  • Pathy NB, Kong YC, Subramaniam S, Goh PP, Ng CW, Yip CH, Pathy NB. Patterns of complementary and alternative medicine use following a cancer diagnosis in Malaysia. Glob Oncol. 2018;4(2):104s–104s. doi:10.1200/jgo.18.74300.
  • Mwaka AD, Okello ES, Orach CG. Barriers to biomedical care and use of traditional medicines for treatment of cervical cancer: an exploratory qualitative study in northern Uganda. Eur J Cancer Care. 2015 Jul;24(4):503–13. doi:10.1111/ecc.12211.
  • Muhamad M, Merriam S, Suhami N. Why breast cancer patients seek traditional healers. Int J Breast Cancer. 2012;2012:689168. doi:10.1155/2012/689168.
  • Bonevski B, Wilson A, Henry DA. An analysis of news media coverage of complementary and alternative medicine. PLoS One. 2008 Jun 11;3(6):e2406. doi:10.1371/journal.pone.0002406.
  • Welz AN, Emberger-Klein A, Menrad K. Why people use herbal medicine: insights from a focus-group study in Germany. BMC Complement Altern Med. 2018 Dec;18(1):92. doi:10.1186/s12906-018-2160-6.
  • Ahmed A, Lee KS, Bukhsh A, Al-Worafi YM, Sarker MM, Ming LC, Khan TM. Outbreak of vaccine-preventable diseases in Muslim majority countries. J Infect Public Health. 2018 Mar 1;11(2):153–55. doi:10.1016/j.jiph.2017.09.007.
  • Khoo YS, Ghani AA, Navamukundan AA, Jahis R, Gamil A. Unique product quality considerations in vaccine development, registration and new program implementation in Malaysia. Hum Vaccin Immunother. 2019 Oct;25:1–9. doi:10.1080/21645515.2019.1667206.
  • Wong LP. HPV information needs, educational messages and channel of delivery preferences: views from developing country with multiethnic populations. Vaccine. 2009a Feb 25;27(9):1410–15. doi:10.1016/j.vaccine.2008.12.045.
  • Larson HJ. Commentary: the uptake of human papillomavirus vaccination: the power of belief. Int J Epidemiol. 2013 Jun;42(3):908–10. doi:10.1093/ije/dyt096.
  • Wong LP. Preventing cervical cancer through human papillomavirus vaccination: perspective from focus groups. J Low Genit Tract Dis. 2009b Apr 1;13(2):85–93. doi:10.1097/LGT.0b013e3181865f44.
  • Kementerian Kesihatan Malaysia. Panduan Penggunaan Ubat Ubatan yang Mengandungi Unsur tidak Halal kepada pesakit Muslim di Kementerian Kesihatan Malaysia; 2018 Jan 9 [accessed 2020 Jan 1]. https://www.pharmacy.gov.my/v2/sites/default/files/document-upload/garis-panduan-penggunaan-ubatan-dengan-kandungan-tidak-halal_0.pdf.
  • van Oers MM, Pijlman GP, Vlak JM. Thirty years of baculovirus–insect cell protein expression: from dark horse to mainstream technology. J Gen Virol. 2015 Jan 1;96(1):6–23. doi:10.1099/vir.0.067108-0.
  • Pejabat Mufti Wilayah Persekutuan. Bayan Linnas Siri ke 167. Kewajiban mengambil vaksin mengikut Jadual Imunisasi Kebangsaan daripada perspektif Islam; 2019 Feb 18 [accessed 2020 Jan 1]. https://muftiwp.gov.my/ms/artikel/bayan-linnas/3129-bayan-linnas-siri-ke-166-kewajiban-mengambil-vaksin-mengikut-jadual-imunisasi-kebangsaan-daripada-perspektif-islam.
  • Padmawati RS, Heywood A, Sitaresmi MN, Atthobari J, MacIntyre CR, Soenarto Y, Seale H. Religious and community leaders’ acceptance of rotavirus vaccine introduction in Yogyakarta, Indonesia: a qualitative study. BMC Public Health. 2019 Dec 1;19(1):368. doi:10.1186/s12889-019-6706-4.
  • Jolley D, Douglas KM. The effects of anti-vaccine conspiracy theories on vaccination intentions. PLoS One. 2014 Feb 20;9(2):e89177. doi:10.1371/journal.pone.0089177.
  • Borzello A. Nigeria’s Muslim clerics fear polio vaccine. BBC News. 2004 Jan 16. http://news.bbc.co.uk/2/hi/africa/3400651.stm.
  • Butler D. Nigerian states disrupt campaign to eradicate polio. Nature. 2004;428(6979):109–109. doi:10.1038/428109b.
  • Shen S. CIA Vaccination Program to Catch Bin Laden Makes Middle-East Even More Suspicious of Vaccinations. Foreign Policy In Focus; 2011 Jul 28 [accessed 2019 Dec 1]. https://fpif.org/cia_vaccination_program_to_catch_bin_laden_makes_middle-east_even_more_suspicious_of_vaccinations/.
  • Ladner J, Besson MH, Audureau E, Rodrigues M, Saba J. Experiences and lessons learned from 29 HPV vaccination programs implemented in 19 low and middle-income countries, 2009–2014. BMC Health Serv Res. 2016 Dec;16(1):575. doi:10.1186/s12913-016-1824-5.
  • Yadav K, Singh B, Goswami K. Agreement and concordance regarding reproductive intentions and contraception between husbands and wives in rural Ballabgarh, India. Indian J Community Med. 2010 Jan;35(1):19. doi:10.4103/0970-0218.62548.
  • Najafi-Sharjabad F, Yahya SZ, Hejar Abdul Rahman MH, Manaf RA. Barriers of modern contraceptive practices among Asian women: a mini literature review. Glob J Health Sci. 2013 Sep;5(5):181. doi:10.5539/gjhs.v5n5p181.
  • De Groot AS, Tounkara K, Rochas M, Beseme S, Yekta S, Diallo FS, Tracy JK, Teguete I, Koita OA. Knowledge, attitudes, practices and willingness to vaccinate in preparation for the introduction of HPV vaccines in Bamako, Mali. PLoS One. 2017 Feb 13;12(2):e0171631. doi:10.1371/journal.pone.0171631.
  • Wong LP. Role of men in promoting the uptake of HPV vaccinations: focus groups’ finding from a developing country. Int J Public Health. 2010 Feb 1;55(1):35–42. doi:10.1007/s00038-009-0072-4.
  • Sathian B, Babu MR, van Teijlingen ER, Banerjee I, Roy B, Subramanya SH, Rajesh E, Devkota S. Ethnic variations in perception of human papillomavirus and its vaccination among young women in Nepal. Nepal J Epidemiol. 2017 Mar;7(1):647. doi:10.3126/nje.v7i1.17757.
  • Osamor PE, Grady C. Autonomy and couples’ joint decision-making in healthcare. BMC Med Ethics. 2018 Dec 1;19(1):3. doi:10.1186/s12910-017-0241-6.
  • Acharya DR, Bell JS, Simkhada P, Van Teijlingen ER, Regmi PR. Women’s autonomy in household decision-making: a demographic study in Nepal. Reprod Health. 2010 Dec;7(1):15. doi:10.1186/1742-4755-7-15.
  • Koski AD, Stephenson R, Koenig MR. Physical violence by partner during pregnancy and use of prenatal care in rural India. J Health Popul Nutr. 2011 Jun;29(3):245. doi:10.3329/jhpn.v29i3.7872.
  • Sohn M, Lin L, Jung M. Effects of maternal decisional authority and media use on vaccination for children in Asian Countries. Medicina. 2018 Dec;54(6):105. doi:10.3390/medicina54060105.
  • Ikeda S, Ueda Y, Yagi A, Matsuzaki S, Kobayashi E, Kimura T, Miyagi E, Sekine M, Enomoto T, Kudoh K. HPV vaccination in Japan: what is happening in Japan? Expert Rev Vaccines. 2019;18(4):323–25. doi:10.1080/14760584.2019.1584040.
  • Morimoto A, Ueda Y, Egawa-Takata T, Yagi A, Terai Y, Ohmichi M, Ichimura T, Sumi T, Murata H, Kanzaki H, et al. Effect on HPV vaccination in Japan resulting from news report of adverse events and suspension of governmental recommendation for HPV vaccination. Int J Clin Oncol. 2015 Jun 1;20(3):549–55. doi:10.1007/s10147-014-0723-1.
  • Tsuda K, Yamamoto K, Leppold C, Tanimoto T, Kusumi E, Komatsu T, Kami M. Trends of media coverage on human papillomavirus vaccination in Japanese newspapers. Clin Infect Dis. 2016 Sep 22;ciw647. https://doi.org/10.1186/s12889-019-7097-2.
  • Okuhara T, Ishikawa H, Okada M, Kato M, Kiuchi T. Newspaper coverage before and after the HPV vaccination crisis began in Japan: a text mining analysis. BMC Public Health. 2019 Dec;19(1):770. doi:10.1186/s12889-019-7097-2.
  • Suzuki S, Hosono A. No association between HPV vaccine and reported post-vaccination symptoms in Japanese young women: results of the Nagoya study. Papillomavirus Res. 2018;5:96–103. doi:10.1016/j.pvr.2018.02.002.
  • Yan J, Ouyang Z, Vinnikova A, Chen M. Avoidance of the threats of defective vaccines: how a vaccine scandal influences parents’ protective behavioral response. Health Commun. 2020 Feb 9;1–10. doi:10.1080/10410236.2020.1724638.
  • Zhuang J, Lu Y, Wagner AL, Jiang Q. Profit considerations in vaccine safety-related events in China. Expert Rev Vaccines. 2019 Nov 14;1–3. doi:10.1080/14760584.2019.1688150.
  • Pinghui Z. Private hospital in China closed down after dozens of patients given fake HPV vaccines. South China Morning Post; 2019 Apr 28 [accessed 2020 Jan 11]. https://www.scmp.com/news/china/society/article/3008005/private-hospital-china-closed-down-after-dozens-patients-given.
  • Danqing L. Hong Kong fake HPV vaccines contaminated. ChinaDaily.com. 2019 Aug 8. https://www.chinadaily.com.cn/a/201908/08/WS5d4bdd33a310cf3e35564a31.html.
  • Liu B, Chen R, Zhao M, Zhang X, Wang J, Gao L, Xu J, Wu Q, Ning N. Vaccine confidence in China after the Changsheng vaccine incident: a cross-sectional study. BMC Public Health. 2019 Dec 1; 19(1):1564. doi:10.1186/s12889-019-7945-0.
  • Arie S. HPV: WHO calls for countries to suspend vaccination of boys. BMJ. 2019;367:l6765. doi:10.1136/bmj.l6765.
  • WHO. Weekly Epidemiological Record; 2019b 2019 Nov 22. 94;47:541–60. www.who.int/wer/2019/wer9447/en.
  • WHO. Global market study: HPV; 2018 Sep [accessed 2019 Dec 1]. www.who.int/immunization/programmes_systems/procurement/v3p/platform/module2/WHO_HPV_market_study_public_summary.pdf.
  • Roden RB, Stern PL. Opportunities and challenges for human papillomavirus vaccination in cancer. Nat Rev Cancer. 2018 Apr;18(4):240. doi:10.1038/nrc.2018.13.
  • China National Medical Products Administration (NMPA). First domestic recombinant human papilloma virus vaccine approved in China [Internet]; 2020 [accessed 2020 Jan 1]. http://www.nmpa.gov.cn/WS04/CL2056/373049.html.
  • Zhou L, Hui MK. Symbolic value of foreign products in the People’s Republic of China. J Int Mark. 2003 Jun;11(2):36–58. doi:10.1509/jimk.11.2.36.20163.
  • Nelson C. Understanding Chinese Consumers. China Bussiness Review; 2011 Jul 1 [accessed 2019 Dec 15]. https://www.chinabusinessreview.com/understanding-chinese-consumers/.
  • ICO/IARC. Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases Report; 2019 [accessed 2020 Jan 4]. https://www.hpvcentre.net/statistics/reports/XSX.pdf.
  • de Martel C, Plummer M, Vignat J, Franceschi S. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer. 2017 Aug 15;141(4):664–70. doi:10.1002/ijc.30716.
  • Deeks SL, Tunis MC, Ismail S. National advisory committee on immunization (NACI. Indigenous health: summary of the NACI update on the recommended use of human papillomavirus (HPV) vaccine: nine-valent HPV vaccine two-dose immunization schedule and the use of HPV vaccines in immunocompromised populations. Can Commun Dis Rep. 2017 Jun 1;43(6):138–42 [eCollection 2017 Jun 1]. doi:10.14745/ccdr.v43i07a04.
  • Yahia MB, Jouin-Bortolotti A, Dervaux B. Extending the human papillomavirus vaccination programme to include males in high-income countries: a systematic review of the cost-effectiveness studies. Clin Drug Investig. 2015 Aug 1;35(8):471–85. doi:10.1007/s40261-015-0308-4.
  • Shapiro GK, Perez S, Rosberger Z. Including males in Canadian human papillomavirus vaccination programs: a policy analysis. Cmaj. 2016 Sep 6;188(12):881–86. doi:10.1503/cmaj.150451.
  • WHO. Human papillomavirus vaccines: WHO position paper, May 2017. Releve epidemiologique hebdomadaire. World Health Organization. 2017;92(19):241–68. doi:10.1016/j.vaccine.2017.05.069.
  • Zhang L, Regan DG, Ong JJ, Gambhir M, Chow EP, Zou H, Law M, Hocking J, Fairley CK. Targeted human papillomavirus vaccination for young men who have sex with men in Australia yields significant population benefits and is cost-effective. Vaccine. 2017 Sep 5;35(37):4923–29. doi:10.1016/j.vaccine.2017.07.078.
  • Liddon N, Hood J, Wynn BA, Markowitz LE. Acceptability of human papillomavirus vaccine for males: a review of the literature. J Adolesc Health. 2010 Feb 1;46(2):113–23. doi:10.1016/j.jadohealth.2009.11.199.
  • Newman PA, Logie CH, Doukas N, Asakura K. HPV vaccine acceptability among men: a systematic review and meta-analysis. Sex Transm Infect. 2013 Nov 1;89(7):568–74. doi:10.1136/sextrans-2012-050980.
  • Lynch L, Long M, Moorhead A. Young men, help-seeking, and mental health services: exploring barriers and solutions. Am J Mens Health. 2018 Jan;12(1):138–49. doi:10.1177/1557988315619469.
  • Ng CJ, Tan HM, Low WY. What do Asian men consider as important masculinity attributes? Findings from the Asian men’s attitudes to life events and sexuality (MALES) study. J Mens Health. 2008 Nov 23;5(4):350–55. doi:10.1016/j.jomh.2008.10.005.
  • Cortes RN. P4. 28 Stigma and discrimination experiences in health care settings more evident among transgender people than males having sex with males (MSM) in Indonesia, Malaysia, The Philippines and Timor leste: key results. Sex Transm Infect. 2017;93:A202. doi:10.1136/sextrans-2017-053264.525.
  • Meites E, Markowitz L, Paz-Bailey G, Oster A, NHBS Study Group. HPV vaccine coverage among men who have sex with men-national HPV behavioral surveillance system, United States, 2011. Vaccine. 2014;32:6356–59. doi:10.1016/j.vaccine.2014.09.033.
  • Gerend M, Madkins K, Phillips G, Mustanski B. Predictors of human papillomavirus vaccination among young men who have sex with men. STD. 2016;43(3):185–91. doi:10.1097/OLQ.0000000000000408.
  • Feng Y, Wu Z, Detels R. Evolution of MSM community and experienced stigma among MSM in Chengdu, China. J Acquir Immune Defic Syndr (1999). 2010 Feb;53(Suppl1):S98. doi:10.1097/QAI.0b013e3181c7df71.
  • Cheung T, Lau JT, Wang JZ, Mo PK, Ho YS. Acceptability of HPV vaccines and associations with perceptions related to HPV and HPV vaccines among male baccalaureate students in Hong Kong. PLoS One. 2018 Jun 18;13(6):e0198615. doi:10.1371/journal.pone.0198615.
  • Li X, Cao X, Li Z, Yang Y, Li M, Feng B, Xin H, Zhang H, Gao L. Human Papillomavirus awareness and vaccine acceptability among men who have sex with men from mainland China. Sci Rep. 2019 Jun 19; 9(1):8763. doi:10.1038/s41598-019-45258-0.
  • Tian T, Wang D, Papamichael C, Yan Z, Guoyao S, Zhanlin Z, Mahan Y, Xiaoqing T, Zheng G, Jianghong D. HPV vaccination acceptability among men who have sex with men in Urumqi, China. Hum Vaccin Immunother. 2019 Apr 3;15(4):1005–12. doi:10.1080/21645515.2018.1520591.
  • Apaydin KZ, Fontenot HB, Shtasel D, Dale SK, Borba CP, Lathan CS, Panther L, Mayer KH, Keuroghlian AS. Facilitators of and barriers to HPV vaccination among sexual and gender minority patients at a Boston community health center. Vaccine. 2018 Jun 18;36(26):3868–75. doi:10.1016/j.vaccine.2018.02.043.
  • Kang HY, Kim JS. Knowledge, attitudes of human papillomavirus vaccine, and intention to obtain vaccine among Korean female undergraduate students. Women Health. 2011 Nov 30;51(8):759–76. doi:10.1080/03630242.2011.627091.
  • Wong LP. Knowledge and attitudes about HPV infection, HPV vaccination, and cervical cancer among rural Southeast Asian women. Int J Behav Med. 2011 Jun 1;18(2):105–11. doi:10.1007/s12529-010-9104-y.
  • Kim JS, Kang HY. Mothers’ knowledge, health beliefs and intentions to vaccinate their daughters against human papillomavirus in Korea. Contemp Nurse. 2014 Apr 1;47(1–2):97–107. doi:10.5172/conu.2014.47.1-2.97.
  • Gu C, Niccolai LM, Yang S, Wang X, Tao L. Human papillomavirus vaccine acceptability among female undergraduate students in China: the role of knowledge and psychosocial factors. J Clin Nurs. 2015 Oct;24(19–20):2765–78. doi:10.1111/jocn.12871.
  • Yu Y, Xu M, Sun J, Li R, Li M, Wang J, Zhang D, Xu A. Human papillomavirus infection and vaccination: awareness and knowledge of HPV and acceptability of HPV vaccine among mothers of teenage daughters in Weihai, Shandong, China. PLoS One. 2016 Jan 14;11(1):e0146741. doi:10.1371/journal.pone.0146741.
  • Cha KS, Kim KM. The factors related to mothers’ intention to vaccinate against hepatitis A: applying the theory of planned behavior. Child Health Nurs Res. 2019 Jan 29;25(1):1–8. doi:10.4094/chnr.2019.25.1.1.
  • Lin Y, Lin Z, He F, Hu Z, Zimet GD, Alias H, Wong LP. Factors influencing intention to obtain the HPV vaccine and acceptability of 2-, 4-and 9-valent HPV vaccines: A study of undergraduate female health sciences students in Fujian, China. Vaccine. 2019 Oct 16;37(44):6714–23. doi:10.1016/j.vaccine.2019.09.026;.
  • Siu JY, Fung TK, Leung LH. Social and cultural construction processes involved in HPV vaccine hesitancy among Chinese women: a qualitative study. Int J Equity Health. 2019 Dec;18(1):1–8. doi:10.1186/s12939-019-1052-9.
  • Levin-Zamir D, Leung AY, Dodson S, Rowlands G. Health literacy in selected populations: individuals, families, and communities from the international and cultural perspective. Inf Serv Use. 2017 Jan 1;37(2):131–51. doi:10.3233/ISU-170834.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.